Assessing glycemic and weight-lowering potential of oral semaglutide in type 2 diabetes compared to other GLP-1 receptor agonists in Indian context
Crossref DOI link: https://doi.org/10.1007/s13410-024-01337-1
Published Online: 2024-04-17
Published Print: 2024-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Singh, Awadhesh Kumar
Chawla, Rajeev
Text and Data Mining valid from 2024-04-17
Version of Record valid from 2024-04-17
Article History
First Online: 17 April 2024
Free to read: This content has been made available to all.